| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Chief Technical Officer | Director
2 companies
Moore Alison serves as a Chief Technical Officer at ALLO and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 19 sells. Those positions are worth an estimated $332K at current prices.
Historically, Moore Alison's trades have earned a middling insider score of 69/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +53.7%.
The biggest single holding is CDXS (~$332K) as President And CEO. The recent filings there lean toward selling, a net 16,400 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | CDXS Codexis, Inc. | President And CEO | Sell | 6,335 | $1.36 | $8,619.40 | -2.5% | - | - | |
| Feb 6, 2026 | CDXS Codexis, Inc. | President And CEO | Sell | 3,826 | $1.31 | $5,000.96 | -1.5% | +94.0% | - | |
| Oct 13, 2025 | CDXS Codexis, Inc. | Chief Technical Officer | Sell | 6,239 | $2.51 | $15,629.32 | -3.6% | -32.8% | -47.2% | |
| Mar 15, 2022 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sell | 8,698 | $7.63 | $66,388.35 | -6.7% | +13.5% | -27.4% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sell | 6,164 | $38.14 | $235,089.41 | -5.7% | -35.0% | -80.0% | |
| Oct 13, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sale+OE | 35,264 | $42.00 | $1,481,088.00 | -24.6% | - | - | |
| Oct 9, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sale+OE | 44,574 | $41.00 | $1,827,534.00 | -29.1% | - | - | |
| Oct 6, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sale+OE | 44,574 | $40.00 | $1,782,960.00 | -27.5% | - | - | |
| Mar 16, 2020 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sell | 3,750 | $19.19 | $71,980.13 | -5.6% | - | - | |
| Sep 18, 2019 | ALLO Allogene Therapeutics, Inc. | Chief Technical Officer | Sale+OE | 48,827 | $32.11 | $1,567,666.24 | -42.5% | - | - |